ISPOR - HTA56 The Post-Brexit UK Access Landscape: Does Project Orbis Significantly Accelerate Patient Access for Oncology Drugs in the UK Versus Europe?

Full Text

HTA56 The Post-Brexit UK Access Landscape: Does Project Orbis Significantly Accelerate Patient Access for Oncology Drugs in the UK Versus Europe?

Abstract

Authors

R. Macaulay K.J. Kim K.W. Leong S. Kennedy

Back to Volume 26, Supplemental Issue 6S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now